News & Events

Northern New England Clinical & Translational Research (NNE-CTR) successes, events and news.


Funding, Fellowships & Opportunities

January 24, 2019 by Jennifer Smith

Click here for a curated and updated list of summaries of CTR-relevant opportunities.

Comprehensive Weekly NIH Listings: Current RFAs , Current Parent Announcements
Gund Institute Funded PhD Opportunities
The Gund Institute for Environment at the University of Vermont (UVM) seeks exceptional PhD applicants to start Fall 2020 and conduct interdisciplinary research on global environmental challenges. Applications are due January 15.

The Gund Institute is a newly expanded campus-wide research accelerator, where 180 faculty, global affiliates, postdocs, and graduate students collaborate widely to understand interactions among ecological, social, and economic systems. We explore environmental issues at the interface of four pressing research themes: climate solutions, health and well-being, sustainable agriculture, and resilient communities.  We are committed to ensuring an inclusive environment where diverse voices and perspectives are active and welcome. We encourage applicants who bring diverse perspectives to our community.

- Gund PhD Fellowships: We seek up to four PhD students to work on Gund research themes, especially the connections among them. Students will receive up to four years of support at $32,000 per year, plus tuition.

- Gund Barrett PhD Fellowships: We seek up to two PhD students for a new opportunity provided by the Gund Institute and UVM’s College of Engineering and Mathematical Sciences (CEMS), supported by The Barrett Foundation. Students will receive up to four years of funding, including an annual stipend of $35,000, plus tuition.  All students are eligible for health insurance, and conference and research funds.

For more details, explore Gund PhD Fellowships online.

The Gund Institute catalyzes environmental research, develops real-world solutions to global issues, and connects UVM with leaders in government, business and beyond.

RFA-CA-19-064 Improving the Reach and Quality of Cancer Care in Rural Populations (R01)
The purpose of this Funding Opportunity Announcement (FOA) is to reduce the burden of cancer and improve the quality of cancer care in rural areas among low-income and/or underserved populations. The FOA encourages two types of applications: (1) observational research that includes intervention pilot testing to understand and address predictors of cancer care/treatment and outcomes in rural low-income and/or underserved populations; or (2) intervention research to address known predictors of cancer care/treatment and outcomes in rural low-income and/or underserved populations. The focus for observational studies with pilot testing is understanding and addressing the predictive and/or mediating role of social determinants of health, barriers to care, and treatment. The focus for intervention research is addressing quality of care related to cancer diagnosis, treatment and/or survivorship. Most existing cancer control interventions are not ready for direct implementation and dissemination in low-income rural areas, so applications should seek to develop, adapt, implement, and test interventions. Due Jan. 15, 2020.
Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 Clinical Trial Optional) This RFA encourages research to promote a greater understanding of the challenges faced by rural population groups, for the development (or adoption/adaptation) of evidence-based interventions that can reduce the health risks faced by rural Americans. Both prevention and treatment interventions are needed to address rural health issues. Prevention strategies should address and measure reductions in risk factors and enhancement of protective factors, while treatment approaches would seek to measure and address amelioration of health in individuals living with existing conditions. To accomplish these goals, the research community will be encouraged to use a wide range of culturally appropriate methodological approaches that can enhance access to and acceptability of interventions in rural settings, such as telehealth and community-based prevention research, where appropriate. It is our hope that research supported under this RFA will contribute to our knowledge of the sustainability of health promotion strategies in rural settings. Due Dec 13, 2019
NIGMS hopes to stimulate interest in sepsis research in communities that may not have been aware of the challenges of identifying and treating sepsis patients.  Sepsis research needs new investigators and new approaches to challenging questions of disease heterogeneity.
NOT GM 19-054 NIGMS Priorities for Sepsis Research and NOT GM 19-057 Strategies to Support Acquisition and Use of Biospecimens for Research on Sepsis in Humans have been released in response to recommendations from an advisory council working group on sepsis. Over the next 3-5 years NIGMS will be optimizing its research grant support of preclinical and clinical sepsis studies to most effectively provide fundamental knowledge of human sepsis.  Several specific topics of research interest that involve clinical studies, research organisms, data science and technology development are outlined in NOT GM 19-054.  In addition, two areas of low priority are described:

  • Studies using rodent models of sepsis unless uniquely well-justified in terms of potential for providing novel insights into human sepsis
  • Clinical trials: In general, NIGMS will only consider support of clinical trials that are designed to test strong mechanistic hypotheses and include appropriate patient stratification. NIGMS expects the scientific foundation of all clinical trial applications to be based on data from rigorously designed and controlled human studies that have been published in peer-reviewed literature. NIGMS is unlikely to support large-scale clinical trials unless other NIH institutes/centers or federal agencies provide joint support to optimize trial efficiency, recruitment, and oversight.

Please feel free to reach out to Sarah Dunsmore, the program director for the NIGMS sepsis research portfolio.  She will be glad to discuss NIGMS interests in sepsis research and current funding opportunities for sepsis research at NIGMS and other relevant NIH institutes.
Health Resources & Services Administration (HRSA) FOA – due November 29. The HRSA expects to invest approximately $2 million for this program that helps rural communities develop integrated health care networks, specifically those who do not have a formal history of collaboration. Up to 20 awards will be made to public or nonprofit private rural entities that represent a network and/or consortium of three or more participants.  The goals of the program are to expand access to quality care in underserved areas by creating efficiencies and coordination of care across multiple providers to strengthen the rural health care system.  The program is competitive every year and assists rural health care networks increase the use of health information technology, transition from volume-based to value-based care, and explore alternative health care delivery models. View notice.
NIH Research on Environmental Health Disparities.  The National Institutes of Health (NIH) intend to publish a funding opportunity announcement (FOA) next month for research activities focused on understanding and reducing or eliminating environmentally-driven health disparities. Projects must include a focus on one or more NIH-designated health disparities populations in the United States: Blacks or African Americans, American Indians or Alaska Natives, Asians, Hispanics or Latinos, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities.


Early State Development of Informatics Technologies for Cancer Research & Management (U01)

FOA, RFA-CA-19-039, invites applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as initial tool development or the significant modification of existing tools for new applications.  Due November 21, 2019.


RFA-CA-19-034 Feasibility & Planning Studies for Development of SPOREs to Investigate Cancer Health Disparities (P20)

All applications must propose translational research that will contribute to improved prevention, early detection, diagnosis, and/or treatment of cancers found to disproportionately affect specific racial/ethnic minority populations. Furthermore, all research projects must be focused upon knowledge of human biology with a translational human endpoint proposed.

All the proposed P20 programs must include a minimum of two well-developed translational research projects, as well as contribute significantly to the development of specialized shared resources core facilities, improved research model systems, and collaborative research activities with other institutions, P20 awardees, and/or current SPORE grantees.  Due June 19, 2020 and October 18, 2020.